FOR IMMEDIATE RELEASE:

Jellyfish Protein Shows Potential as an Age-Fighting Dietary Supplement

New York, New York (February 9, 2007)

Quincy Bioscience (Madison, WI) announces that Prevagen Professional™ (www.prevagenpro.com), a dietary supplement consisting of the jellyfish protein aequorin, has displayed potent age-fighting activity in their laboratory studies.

Quincy Bioscience has been researching the jellyfish protein for the past eleven years and will be releasing their first professional strength product derived from that technology as the branded dietary supplement Prevagen Professional™. Specifically, the age-fighting potential displayed by Prevagen Professional™ is an ability to keep more brain cells alive in scientific tests when compared against controls. Laboratory tests show a 50% reduction in cellular death in the rodent models studied. Quincy Bioscience is exhibiting their product and sharing this breakthrough for the first time at the 2007 CAMEXPO East Conference held in New York, New York.

Quincy Bioscience conducts research in partnership with the University of Wisconsin at Milwaukee to develop age-fighting technologies primarily focusing on management of the age related disruption in calcium regulation. This disruption can lead to premature cell death in the brain and in other tissues and systems in the aging human body. Prevagen Professional™ is a novel product that in technical terms is a calcium-binding protein. Calcium-binding proteins deplete in several areas of the body as part of the aging process. Prevagen Professional™ taken as a supplement replaces those proteins lost through aging.

"We are very excited to be bringing this technology out through healthcare practitioners," commented Mark Underwood, the inventor of the aequorin technology and a founder and President of Quincy Bioscience. "Many people are searching for a potent anti-aging supplement that has some really strong science. There isn't anything to fight aging like our product."

A certain species of jellyfish contains the protein aequorin which has the unique property of binding calcium ions in their nervous system. Humans also need this type of protein in their nervous system to properly protect their cells too. One of the detriments of the aging process is that humans lose a significant amount of their own cell-protecting proteins. Aequorin is a very similar type of protein and is completely non-toxic, the reason for its successful development into the supplement product.

"Having strong science is the key to helping people that are interested in natural and alternative health products." added Mike Beaman, Mr. Underwood's business partner. "It is exciting that we can touch the health of so many others immediately through Prevagen Professional™. There are many people that are choosing alternative medicine products that are safer because of their all-natural design and our discovery fits well within that mindset. It simply makes sense."

Quincy Bioscience is a biotechnology company based in Madison, Wisconsin. Quincy Bioscience is focused on the discovery, development and commercialization of novel compounds to fight the aging process. The company's products focus on restoring calcium balance related to neurodegenerative disorders and other destructive age-related mechanisms. Quincy Bioscience is set apart by its cutting-edge health applications of the jellyfish protein aequorin for dietary supplement and pharmaceutical products.

Quincy Bioscience will be exhibiting during the CAMEXPO East Friday, February 9th and 10th at the New York Marriott Marquis (1535 Broadway, New York, NY 10036). Representatives will be on hand in booth # 512 with literature. For more information visit www.prevagenpro.com.

* These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.

For more information, contact Mark Underwood, President at munderwood@quincybioscience.com or 414-303-0814.